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To clarify the effects of Gd-DTPA on biological water, we examined the effects of the 
compound on spin-lattice relaxation rate with various concentrations of gelatin solutions. 
The results indicate that the effects on relaxation rate of Gd-DTPA in biological water 
fundamentally correspond to those in aqueous solution. To evaluate the distribution of 
Gd-DTPA in tissues, we introduced a transfer index that represents the product of 
tissue-blood ratio of Gd-DTPA and the ratio of extracellular volume of a tissue based on 
the above findings. The index depends neither on dose of the compound nor on Larmor 
frequency. The clinical significance of the index was studied in patients with brain 
tumors. The indexes varied from 0.038 to 0.51, depending on the biological character-
istics of the tumors. 
The transfer index may be used in the quantitative evaluation of MR relaxation 
enhancement, which may be applied to monitoring therapeutic efficacy and to estimating 
tissue perfusion. 
Recent clinical experiences with MR imaging have shown a rather low specificity 
for the recognition of pathology in contrast with a high sensitivity for the detection 
of lesions [1] . Gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) is the first 
practical contrast agent for MR that is expected to improve diagnostic capability. 
Although the clinical usefulness of Gd-DTPA has been generally acknowledged , in 
particular for the CNS [1-3] , it is not so clear how and to what extent the relaxation 
rates for biological tissues are changed when the compound is administered. 
This study was designed to examine comparatively the spin-lattice relaxation-
rate effects of Gd-DTPA on different substances, such as gelatin solutions, blood 
samples, and in vivo brain lesions. In this paper we stress that the principal effects 
of Gd-DTPA on proton spin-lattice relaxation rates for tissues are the same as 
those on rates for aqueous solutions, and propose the concept of a transfer index, 
which may play a role in featuring the characteristics of biological tissues. 
Rationale of Behavior of Gd-DTPA in Biological Water and the Transfer Index 
It is well known that the relation between the proton spin-lattice relaxation rate 
and the Gd-DTPA concentration in aqueous solutions is expressed by the following 
equation [4, 5]: 
R1 ' =k .C+R1 (1) 
where R1 is the intrinsic relaxation rate for distilled water and R1 ' is the relaxation 
rate for the solution at C mmol/1 of Gd-DTPA. The value of k represents the 
relaxivity of Gd-DTPA, influenced by the chemical environment of Gd-DTPA in a 
solution as well as by Larmor frequency [6]. 
Biological water is divided into two components , free and bound (hydrated) 
water, according to the theory of a two-component fast-exchange model [7-9]. In 
general, the free water fraction occupies the major part of biological water and its 
330 KANEOKE ET AL. AJNR :1 0, March/April1989 
relaxation rate is much smaller than that for bound water. 
Free water is regarded as being equal to distilled water in 
nature [7, 9], so that the effects of Gd-DTPA on free water 
relaxation rates should be the same as those on distilled 
water relaxation rates. Although the effects of the compound 
on bound water relaxation rates should differ from those on 
distilled water relaxation rates, the effects may be inadequate 
to distinguish them from the effects on free water relaxation 
rates owing to the much higher relaxation rates for bound 
water [5, 7, 1 0]. 
From the above, one can see that relaxation-rate changes 
in biological water due to Gd-DTPA should be derived from 
the changes in relaxation rate for the free water. This means 
that equation (1) can be applied to biological water. Changes 
in relaxation rate for plasma should be given as follows: 
R1p ' = k -Cp + R1p (2) 
where R1 pis the intrinsic relaxation rate for plasma and R1 p' 
is the plasma relaxation rate at the concentration of Cp mmol/ 
1 of water in plasma. The value of k, the relaxivity of Gd-
DTPA for biological water, should be equal to that for aqueous 
solutions [4, 11 ]. 
Since Gd-DTPA never enters cells [4, 11 ], the effects of 
the compound on whole blood are considered to be a com-
bination of those on plasma and blood cells. Accordingly, the 
following equation [7] is applicable to predict relaxation rate 
for blood after administration of the compound: 
R1b = (1- h) -R1p + h -R1c (3) 
where R 1 b is the relaxation rate for whole blood and R 1 c is 
the relaxation rate for red blood cells ; his hematocrit. Because 
no difference in relaxation rate for red blood cells is expected 
before or after administration of Gd-DTPA, the whole blood 
relaxation rate (R1 b' ) at the concentration of Cp mmol per 
plasma water can be expressed by the following equation 
derived from equations (2) and (3): 
R1b ' = k-(1-h) -Cp + R1b (4) 
If the tissue relaxation rate is represented by the summation 
of relaxation rates in cellular and extracellular space in a same 
manner as blood in equation (3) , the following equation is 
obtained for biological tissue: 
R1t ' = k .f.Ct + R1t (5) 
where R1t and R1t ' are the respective relaxation rates for 
tissue before and after Gd-DTPA administration and f is the 
ratio of volume of extracellular space to total tissue volume; 
Ct is the Gd-DTPA concentration of mmol/1 of extracellular 
water. 
Equation (5) , derived from the above assumption, corre-
sponds well to the results of Strich et al. [12]. Therefore, the 
equation can be used for brain lesions and various other 
tissues (but not for normal brain tissue), although the as-
sumption has not yet been proved. 
Concern ing the contribution of Gd-DTPA to both compart-
ments of tissue and blood , the following equation is derived 
from equations (4) and (5), indicating the tissue-blood ratio of 
the compound administered: 
f .CtjCp = (1-h) -t. R1t/b. R1b 
{b. R1t=R1t ' -R1t; t. R1b=R1b' -R1b) {6) 
The left side of the equation, represented as the product 
of the tissue-blood ratio of the compound (CtjCp) and the 
ratio of extracellular volume (f), can be readily derived from 
the values of relaxation rates, which can be quantitatively 
obtained as shown in the right side of the equation . We 
propose this value, calculated by equation (6), as the transfer 
index of Gd-DTPA intravenously administered for each biolog-
ical tissue, which should vary with state of tissue perfusion, 
blood-tissue permeability, edema, and many other pathologic 
conditions. CtfCp will be changed by tissue perfusion and 
blood-tissue permeability; the value of f will be changed by 
edematous state. This index ought to be independent of both 
the dose of the compound and the Larmor frequency. The 
time at which the index is measured after administration of 
the compound will cause the implications of the index to vary, 
since the time dependence of Ct/Cp will be changed by local 
cerebral blood flow mainly in the early and late stages by the 
vascular architecture of a tissue, blood-tissue permeability, 
and so on. 
Materials and Methods 
Measurements of proton spin-lattice relaxation times (T1) were 
taken in a series of gelatin solutions containing various concentrations 
of Gd-DTPA as well as in patients with brain tumors. In clinical 
observations the values of T1 were examined comparatively before 
and after Gd-DTPA administration. The values of in vitro and in vivo 
relaxation rates were measured at 2.12 MHz (0.047 T) utilizing Fonar 
QED 80-alpha with the progressive saturation method (90° - T -90°) 
and the field focusing technique. Thirteen values of T, ranging from 
25 to 2000 msec, were used to accumulate FID signals. In each value 
of T seven FID signals were accumulated for noise reduction. Values 
of T1 were calculated from 13 signal intensities. Absolute uncertainty 
in measurement of T1 (standard deviation) was around 5%. Details 
of the method have been given elsewhere [13). 
Gelatin Solution Series 
Five concentrations of Gd-DTPA solution , containing 0.031 , 0.31 , 
0.50, and 2.0 mmolfl , were prepared by dilution of 0.5 molfl Gd-DTPA 
solution• with distilled water. Weighed gelatin' was mixed with each 
of the above Gd-DTPA solutions to make five kinds of solutions, with 
10, 20, 30, 40, and 50 wt%. This solution series, which consisted of 
25 kinds of concentrations of gelatin and Gd-DTPA, was used to 
measure in vitro values of relaxation times. The values obtained were 
compared with the intrinsic relaxation times for gelatin without Gd-
DTPA. 
Clinical Observation 
Ten patients with brain tumors and brain abscess were studied to 
measure in vivo relaxation times for brain tissues . Relaxation times 
for the regions of interest in the tissues of brain tumors, peritumoral 
• Shering AG, Berlin, West Germany. 
' Wako Pure Chemical Industries, ltd., Osaka, Japan. 
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edema, and normal white matter were measured, respectively, before 
and after IV administration of 0.1 0 mmolfkg of Gd-DTPA every 60 
sec up to 30 min. The sites of relaxation-time measurements were 
determined from MR images as well as from CT findings. 
In each measurement of brain relaxation rates, venous blood 
samples were collected in heparinized bottles before and 5, 1 0, 15, 
and 30 min after administration of the compound. Each 4 ml of blood 
sample were used to measure relaxation time by the same MR 
system with an original coil that was designed to measure relaxation 
times for small materials after all measurements of brain relaxation 
times. Relaxation times for blood samples were measured at 21 oc 
and their changes were corrected to be the values at 37°C by the 
relaxivity of Gd-DTPA at 37° C (7 .0 mmol- ' . sec-' ). 
Results 
Changes in Relaxation Times Associated with 
Concentrations of Gd-DTPA and Gelatin 
Table 1 indicates the relaxation times (T1) obtained from 
various concentrations of gelatin and Gd-DTPA. Changes in 
T1 values were found to be inversely proportional to concen-
trations of gelatin and Gd-DTPA. Contribution of Gd-DTPA to 
T1 values was outstanding in high ranges of intrinsic T1 value 
compared with the low ranges of T1: the intrinsic T1 value of 
552 msec measured in 1 0% gelatin solutions was reduced to 
164 msec at 0.5 mmoljl of Gd-DTPA concentration , whereas 
the T1 value of 52 msec in 50% gelatin solution was reduced 
to only 44 msec at the same concentration of Gd-DTPA. 
The measured T1 values for various gelatin solutions with 
Gd-DTPA corresponded closely to the T1 values calculated 
by equation (1) from the intrinsic T1 values without Gd-DTPA. 
The value of 7.7 mmol- '. sec-' was used for the value of k 
in equation (1 ), which was determined as the relaxivity of Gd-
DTPA in distilled water at 21 °C. Figure 1 shows a plot of 
measured T1 values against calculated T1 values. Good 
agreement is demonstrated between calculated and meas-
ured relaxation times, although there is a small amount of 
deviation of T1 , possibly owing to measurement errors at 
smaller T1 ranges. 
In Vivo T1 Changes Before and After Gd-DTPA 
Administration and Transfer Indexes in Patients with Brain 
Tumors 
In all cases of brain tumors , no significant differences in T1 
values were noted for normal white matter and peritumoral 
tissues either before or after IV administration of Gd-DTPA. 
In contrast , relaxation times for the lesion sites of the brain 
tumors changed consistently, attaining maximum values of 
relaxation rates (1 fT1) within 15 min after Gd-DTPA adminis-
tration . In blood samples, the value of relaxation rates moved 
more rapidly and reached the maximum about 5 min after 
injection. An illustrative example of the changes in relaxation 
rate is shown in Figure 2. 
Table 2 shows the T1 values for the sites of brain tumors 
before and 5 min after Gd-DTPA administration and the 
transfer indexes calculated from those values. Transfer in-
dexes varied from 0.038 to 0.51 . In meningiomas, the transfer 
index varied in the same range, and an exclusively high value 
was found in a case of meningioma (case 4) that invaded the 
paranasal sinuses and was judged by pathology to be sar-
comatous. A case of glioma (case 5) showed the value of 
0.11 in the transfer index. In metastatic tumors the indexes 
varied from 0.049 to 0.25 . The metastatic tumor (case 9), 
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Fig. 1.-Logarithmic plot of measured T1 versus calculated T1 for 
gelatin and Gd-DTPA solution. Solid line represents curve best fit to the 
data; it shows good agreement with dotted line, which expresses perfect 
agreement. 
TABLE 1: Values of In Vitro T1 with Different Gelatin and Gd-DTPA Concentrations 
Gelatin Gd-DTPA Concentration (mmolfl) 
Concentration(%) 0 0.031 0.13 0.5 1.0 2.0 
10 552±15* 490 ± 10 342 ± 9 164 ± 6 97 ± 5 55± 2 
20 255 ± 5 236 ± 9 202 ± 5 116 ± 4 83 ± 3 46 ± 2 
30 141 ± 7 140 ± 6 118 ± 2 81 ± 3 61 ± 3 38 ± 1 
40 82 ± 4 75 ± 6 74 ± 2 58 ± 6 45 ± 5 30 ± 2 
50 52± 5 49 ± 6 43 ± 2 44 ± 5 31 ± 3 23 ± 3 
• T1 values expressed in msec ± SD. 
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Discussion 
Several investigators have mentioned the excellent efficacy 
of Gd-DTPA for discriminating between the characteristics of 
various tissues and pathologies [1-3, 14-16] . Use of this 
contrast enhancer is actually opening a new aspect of MR 
capability in tissue characterization, particularly in diagnosing 
brain tumors and distinguishing them from edematous proc-
esses. In most investigations, however, the authors discussed 
only whether a lesion was enhanced in MR imaging and 
slighted the quantitative estimation of contrast enhancement. 
It is expected that quantitative evaluation of the enhancement 
of tissues or lesions will give us further information about their 
pathologic characteristics [16] . 
Such a quantitative study of the effects of an enhancer can 
be readily done by measurement of T1 values or signal 
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Fig. 2.- Time courses of relaxation rates for blood and metastatic tumor 
(case 9 in Table 2). 
intensity for tissues before and after administration of Gd-
DTPA. The data of T1 and signal intensity present difficulties 
in clinical evaluation for various reasons , such as T1 differ-
ences in individuals and in tissues, varieties of Larmor fre-
quencies used, and variations in dose of the compound 
administered. For actual application to clinical practice, a 
universal index is needed that is never influenced by the 
above factors . From the fundamental observations on gelatin 
solutions, the changes in the relaxation rates were found to 
be well represented in a manner similar to those in aqueous 
water within the dose range of Gd-DTPA in clinical usage. 
The present results indicate that the effects of Gd-DTPA on 
biological water principally originated in the free water fraction 
of the system. Accordingly, such evidence can be readi ly 
applied to deal with the changes in relaxation rates for biolog-
ical water, such as in plasma, and extracellular water in 
tissues . 
The transfer index, proposed as (1-h) . 6 R 1t/ 6 R 1 b in the 
present study, represents the product of the tissue-blood 
ratio of the compound and the ratio of extracellular volume. 
The index will be varied by tissue perfusion, blood-tissue 
permeability, edema, and many other pathologic conditions . 
Furthermore, this index possesses important features as a 
universal parameter for evaluation of MR enhancement, since 
the values attained are independent not only of differences in 
Larmor frequency but also of the given dose of the contrast 
enhancer. 
Variability and validity of the transfer index in biological 
organs were examined and are shown in Table 3, extrapolated 
from the data published by Wolf and Fobben [17], in which in 
vitro T1 for various rabbit tissues were determined after Gd-
DTPA administration. There is significant variabi lity in the 
transfer indexes among tissues, ranging from 0.08 to 2.7. 
Markedly high index values are seen in the renal medulla and 
cortex, 2.7 and 1.4, respectively, probably owing to high 
accumulation of Gd-DTPA in the organ . Relatively high values 
of the index found in pancreas and heart may be due to their 
high tissue perfusion . 
It is reasonable to assume that in pathologic central nervous 
tissues the values of the transfer index must be influenced by 
the mode and extent of blood-brain barrier disturbances as 
well as by the state of tissue perfusion . As represented in the 
TABLE 2: Differences in Relaxation Times and Rates for Brain Lesions Before and After Gd-
DTPA Administration, and Their Transfer Indexes 
Case Type of T1 T1 ' 6. R1t 6. R1 b Hct 
Transfer 
No. Brain Lesion Index 
1 Meningioma 376 236 1.58 26.0 0.376 0.038 
2 Meningioma 281 202 1.39 16.5 0.384 0.052 
3 Meningioma 323 254 0.840 5.52 0.371 0.096 
4 Meningioma 311 152 3.36 4.40 0.334 0.51 
5 Glioblastoma 391 293 0.855 4.54 0.439 0.11 
6 Metastasis 991 652 0.53 6.97 0.352 0.049 
7 Metastasis 369 335 0.275 3.43 0.328 0.054 
8 Metastasis 353 275 0.795 9.25 0.367 0.054 
9 Metastasis 263 179 1.79 4.57 0.356 0.25 
10 Abscess 349 246 1.20 3.39 0.242 0.27 
Note.- T1 = relaxation time for brain lesion before Gd-DTPA administration (msec); T1 ' = relaxation time for brain 
lesion after Gd-DTPA administration (msec); ~R 1 t = relaxation rate difference in tissue (sec- '); ~ R1 b = relaxation 
rate difference in blood (sec- ' ); Hct = hematocrit. 
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TABLE 3: MR Relaxation Rates and Transfer Indexes for 
Various Rabbit Tissues 
Tissue R1 R1 ' Transfer Index 
Renal medulla 2.67 21.3 2.7 
Renal cortex 4.83 13.9 1.4 
Pancreas 5.71 7.75 0.30 
Heart 3.57 502 0.22 
Lung 3.22 4.44 0.18 
Skeletal muscle 4.59 5.78 0.18 
Liver 5.85 6.90 0.15 
Spleen 3.85 4.44 0.08 
Blood 1.75 5.92 
Note.-R1 =relaxation rate before Gd-DTPA administration (sec- ') ; R1 ' = 
relaxation rate 15 min after Gd-DTPA administration (sec- ' ) (value of hematocrit 
is assumed to be 0.40. Utilized values are derived from the data from Wolf and 
Fobben (17]). 
study, the index observed in various brain lesions ranged 
from 0.038 to 0.51. High index values were found in active 
and invasive tumors in meningioma and metastatic tumor 
compared with other tumors of the same kind. The capsule 
of a brain abscess had a relatively high index value, namely, 
0.27 . A rather low index value for the glioblastoma may be 
due to radiation therapy. 
Obviously, there is no simple correlation between patho-
logic malignancy of tumors and the degree of Gd-DTPA shift 
into tumors, because blood-tissue permeability of Gd-DTPA 
or blood-brain barrier breakdown in tumorous tissues de-
pends not only on the growth states but also on the differ-
ences in tissue origin such as extra- or intraaxial structures. 
This transfer index, however, has an outstanding significance 
in quantitative evaluation on the enhancing effects of the 
contrast agent. 
Figure 2 indicates that the transfer index will depend sig-
nificantly on the time the value is measured. The values of 
transfer index described in the present study were calculated 
from the T1 values attained 5 min after Gd-DTPA administra-
tion . Because of rather rapid renal excretion of Gd-DTPA 
[4], utilization of the value at the earlier phase is considered 
to be more reliable for estimation of blood-tissue distribution . 
Such immediate values also may be a good marker for 
indicating the state of the tissue perfusion [12]. The index 
measured in later phase may reflect vascular architecture, 
and so on. Thus, we may be able to obtain further information 
about a lesion from two or more values of the index measured 
at various times after Gd-DTPA administration. 
For the calculation of the transfer index, sampling of blood 
is required as an unavoidable procedure. It is also necessary 
to measure in vivo T1 values as accurately as possible. 
Measurement errors of transfer index will be four t imes as 
large as those of T1 according to mathematical estimation. In 
spite of these complexities in methodology, the evidence is 
convincing that application of this transfer index to evaluate 
the degree of enhancement in MR opens possibilities for 
discriminating tumor characteristics. Furthermore, the present 
studies indicate that this index may also be used for estimat-
ing tissue perfusion and sensitivities to tumor therapies, al-
though further investigations are needed to clarify such is-
sues. 
In conclusion, the relaxation rate effects of Gd-DTPA on 
various solutions depend essentially only on the concentration 
of the compound in the solutions. On the basis of our findings, 
we introduce the transfer index of Gd-DTPA for MR . The 
index depends on the tissue-blood ratio of Gd-DTPA concen-
tration and on the volume of extracellular fluid . The value 
proposed depends neither on the dose of the compounds nor 
on Larmor frequency . Therefore, the index should by useful 
as a universal parameter for MR that depends on pathologic 
changes in biological tissues . The index may be used to 
evaluate local blood flow of tissues, blood-tissue permeability , 
the effects of therapy on tumors, and malignancy of tumors. 
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